Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites
The overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascit...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-11-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317726840 |
id |
doaj-9d31df12c04d4c4ba5a780a8717fb7a5 |
---|---|
record_format |
Article |
spelling |
doaj-9d31df12c04d4c4ba5a780a8717fb7a52021-05-02T18:36:48ZengIOS PressTumor Biology1423-03802017-11-013910.1177/1010428317726840Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascitesJuan Sun0Yan-Xiang Chang1Chun-Yan Niu2Xi’an Medical University, Xi’an, ChinaDepartment of Oncology, The First Affiliated Hospital of Xi’an Medical University, Xi’an, ChinaDepartment of Gastroenterology, The First Affiliated Hospital of Xi’an Medical University, Xi’an, ChinaThe overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascites. Enzyme-linked immunosorbent assay was used to detect soluble human leukocyte antigen-G levels in 64 patients with malignant ascites and 30 patients with benign ascites. Receiver operating characteristic curves were used to evaluate the diagnostic efficacy of ascitic soluble human leukocyte antigen-G for the detection of malignant ascites. Ascitic soluble human leukocyte antigen-G levels were significantly higher in the malignant ascites group than in the benign ascites group (20.718 ± 3.215 versus 12.467 ± 3.678 µg/L, t = 7.425, p < 0.001). The area under the receiver operating characteristic curve for ascitic soluble human leukocyte antigen-G was 0.957 (95% confidence interval, 0.872–0.992). At a cut-off value of 19.60 µg/L, the sensitivity and specificity of ascitic soluble human leukocyte antigen-G were 87.5% (95% confidence interval, 71.0%–96.5%) and 100% (95% confidence interval, 88.4%–100%), respectively. With respect to area under the receiver operating characteristic curve, sensitivity and specificity, ascitic carcinoembryonic antigen (0.810, 68.75% and 83.33%, respectively) and carbohydrate antigen 19-9 (0.710, 65.63% and 70%, respectively) significantly differed (all p < 0.05). In malignant ascites that were cytology-negative and biopsy-positive, the rate of positivity for ascitic soluble human leukocyte antigen-G was 75%, which was higher than the corresponding rates for ascitic carcinoembryonic antigen (31.25%) and carbohydrate antigen 19-9 (6.25%; both p < 0.05). In conclusion, The detection of ascitic soluble human leukocyte antigen-G exhibited good performance for diagnosing malignant ascites, and particularly those that were cytology-negative and biopsy-positive.https://doi.org/10.1177/1010428317726840 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Juan Sun Yan-Xiang Chang Chun-Yan Niu |
spellingShingle |
Juan Sun Yan-Xiang Chang Chun-Yan Niu Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites Tumor Biology |
author_facet |
Juan Sun Yan-Xiang Chang Chun-Yan Niu |
author_sort |
Juan Sun |
title |
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites |
title_short |
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites |
title_full |
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites |
title_fullStr |
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites |
title_full_unstemmed |
Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites |
title_sort |
evaluation of ascitic soluble human leukocyte antigen-g for distinguishing malignant ascites from benign ascites |
publisher |
IOS Press |
series |
Tumor Biology |
issn |
1423-0380 |
publishDate |
2017-11-01 |
description |
The overexpression of soluble human leukocyte antigen-G is associated with malignant tumours. The purpose of our study was to detect soluble human leukocyte antigen-G concentrations in ascites and to evaluate the value of ascitic soluble human leukocyte antigen-G for the diagnosis of malignant ascites. Enzyme-linked immunosorbent assay was used to detect soluble human leukocyte antigen-G levels in 64 patients with malignant ascites and 30 patients with benign ascites. Receiver operating characteristic curves were used to evaluate the diagnostic efficacy of ascitic soluble human leukocyte antigen-G for the detection of malignant ascites. Ascitic soluble human leukocyte antigen-G levels were significantly higher in the malignant ascites group than in the benign ascites group (20.718 ± 3.215 versus 12.467 ± 3.678 µg/L, t = 7.425, p < 0.001). The area under the receiver operating characteristic curve for ascitic soluble human leukocyte antigen-G was 0.957 (95% confidence interval, 0.872–0.992). At a cut-off value of 19.60 µg/L, the sensitivity and specificity of ascitic soluble human leukocyte antigen-G were 87.5% (95% confidence interval, 71.0%–96.5%) and 100% (95% confidence interval, 88.4%–100%), respectively. With respect to area under the receiver operating characteristic curve, sensitivity and specificity, ascitic carcinoembryonic antigen (0.810, 68.75% and 83.33%, respectively) and carbohydrate antigen 19-9 (0.710, 65.63% and 70%, respectively) significantly differed (all p < 0.05). In malignant ascites that were cytology-negative and biopsy-positive, the rate of positivity for ascitic soluble human leukocyte antigen-G was 75%, which was higher than the corresponding rates for ascitic carcinoembryonic antigen (31.25%) and carbohydrate antigen 19-9 (6.25%; both p < 0.05). In conclusion, The detection of ascitic soluble human leukocyte antigen-G exhibited good performance for diagnosing malignant ascites, and particularly those that were cytology-negative and biopsy-positive. |
url |
https://doi.org/10.1177/1010428317726840 |
work_keys_str_mv |
AT juansun evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites AT yanxiangchang evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites AT chunyanniu evaluationofasciticsolublehumanleukocyteantigengfordistinguishingmalignantascitesfrombenignascites |
_version_ |
1721488786486984704 |